The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients

The Short Form-36: Pre-vs. Post-Surgical Administration in Cardiac Surgery Patients

The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

Inclusion Criteria:

• Cardiac surgery patients who are between the ages of 18 and 100

• Are English speaking

• Able to give consent

• Undergoing cardiac surgery including (but not limited to):

  • Aortic valve replacement (AVR)
  • Mitral valve replacement (MVR)
  • Tricuspid valve replacement (TVR)
  • Coronary artery bypass graft (CABG).

Exclusion Criteria:

• Non-cardiac surgery patients